Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Neurophet
No Price
Closing Price XKOS 30.04.2026:
20.100,00 KRW
30.04.2026 06:30
Current Prices from Neurophet
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
KOSDAQ
380550.KQ
KRW
30.04.2026 06:30
20.100,00 KRW
-
Share Float & Liquidity
Free Float63,38 %
Shares Float7,66 M
Shares Outstanding12,09 M
Company Profile for Neurophet Share
Neurophet, Inc., operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases. The company offers Neurophet AQUA, AI-powered diagnosis assistant software for brain diseases; Neurophet SCALE PET, a software that quantitatively analyzes biomarkers targeted by a specific radiotracer using PET; Neurophet tES LAB, AI-Powered software to generate a 3D model using brain MRI and simulate electrical stimulation for treatment planning; and Neurophet innk, a non-invasive electrical stimulation device designed to aid in the functional recovery and rehabilitation of patients with brain diseases. It also provides Consulting services for design systems and quality management systems. The company was founded in 2016 and is headquartered in Seoul, South Korea.
